CCNC

cyclin C, the group of Cyclins|Mediator complex

Basic information

Region (hg38): 6:99542387-99568825

Links

ENSG00000112237NCBI:892OMIM:123838HGNC:1581Uniprot:P24863AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CCNC gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCNC gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
9
clinvar
9
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 9 0 0

Variants in CCNC

This is a list of pathogenic ClinVar variants found in the CCNC region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-99545143-T-G not specified Uncertain significance (Jan 08, 2024)3139895
6-99545155-T-C not specified Uncertain significance (Jul 16, 2021)2238024
6-99546446-C-A not specified Uncertain significance (Feb 05, 2024)3139894
6-99551877-T-A not specified Uncertain significance (Mar 01, 2024)3139893
6-99551879-T-C not specified Likely benign (Feb 09, 2025)3829081
6-99558419-T-TA CIC-rearranged sarcoma not provided (-)805963
6-99558500-C-T not specified Uncertain significance (Feb 06, 2024)3139892
6-99561389-A-C not specified Uncertain significance (Jun 17, 2024)3264538
6-99561435-A-C not specified Uncertain significance (Feb 06, 2024)3139891
6-99561603-T-C not specified Uncertain significance (Oct 14, 2023)3139890
6-99562908-G-A not specified Uncertain significance (Jun 10, 2024)3264537

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CCNCprotein_codingprotein_codingENST00000520429 1226594
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.000864125235011252360.00000399
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.25631370.4590.000006181870
Missense in Polyphen1947.8370.39718641
Synonymous0.4024245.40.9240.00000219467
Loss of Function4.19020.40.008.62e-7278

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.00003290.0000329
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Binds to and activates cyclin-dependent kinase CDK8 that phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. {ECO:0000269|PubMed:16595664, ECO:0000269|PubMed:8700522}.;
Pathway
Vitamin D Receptor Pathway;Developmental Biology;Disease;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by NOTCH1;Signaling by NOTCH;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Signaling by TGF-beta Receptor Complex;Signaling by TGF-beta family members;Diseases of signal transduction;NOTCH1 Intracellular Domain Regulates Transcription (Consensus)

Recessive Scores

pRec
0.194

Intolerance Scores

loftool
0.537
rvis_EVS
-0.1
rvis_percentile_EVS
46.2

Haploinsufficiency Scores

pHI
0.951
hipred
Y
hipred_score
0.783
ghis
0.677

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
0.967

Gene Damage Prediction

AllRecessiveDominant
MendelianLowLowLow
Primary ImmunodeficiencyLowLowLow
CancerLowLowLow

Mouse Genome Informatics

Gene name
Ccnc
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; embryo phenotype; growth/size/body region phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
ccnc
Affected structure
pronephric podocyte
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
regulation of cyclin-dependent protein serine/threonine kinase activity;regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;protein phosphorylation;positive regulation of transcription by RNA polymerase II
Cellular component
nucleus;nucleoplasm;mediator complex
Molecular function
protein serine/threonine kinase activity;protein binding;cyclin-dependent protein serine/threonine kinase regulator activity